X

Vous n'êtes pas connecté

Rubriques :

Maroc Maroc - DRUGS.COM - Daily MedNews - Hier 09:09

Some People With MS May Need Earlier, Higher-Dose Meds

WEDNESDAY, Sept. 18, 2024 -- Early, aggressive treatment of brain lesions caused by multiple sclerosis could help ward off faster decline in patients, a new study finds. Such treatment could prevent or potentially cure paramagnetic rim lesions...

Articles similaires

Sorry! Image not available at this time

Could 'Brain Training' Exercises Help Slow Alzheimer's Symptoms?

drugs.com - 17/Sep 09:37

TUESDAY, Sept. 17, 2024 -- Brain training aimed at improving memory can ward off symptoms of Alzheimer’s disease for years, a new study...

Sorry! Image not available at this time

Quantum BioPharma to run multiple sclerosis progression study

themarketherald.ca - 09/Sep 17:24

Quantum BioPharma (CSE:QNTM) will conduct a study observing disease progression in patients with primary progressive multiple sclerosis.

Sorry! Image not available at this time

Could Sulthiame, a Pill Approved in Europe for Epilepsy, Help Ease Sleep Apnea?

drugs.com - 10/Sep 12:09

TUESDAY, Sept. 10, 2024 -- A European epilepsy drug could be an effective treatment for sleep apnea, a new study suggests. Patients who took sulthiame...

Sorry! Image not available at this time

Epilepsy drug could reduce sleep apnoea symptoms, study finds

theguardian.com - 10/Sep 12:15

Sulthiame may help prevent patients’ breathing from temporarily stopping, international research suggests

Sorry! Image not available at this time

Early Treatment Cuts Long-Term Disability in Kids With Multiple Sclerosis

medindia.net - 13:52

New research highlights the benefits of starting monoclonal antibody therapy for medlinkmultiple sclerosis/medlink in childhood. The study,...

Sorry! Image not available at this time

New Data for BRIUMVI® (ublituximab-xiiy) Demonstrate that 92% of Patients with Relapsing Multiple Sclerosis Were Free from Disability Progression After 5 Years of Treatment

healthtechzone.com - 11:00

Sorry! Image not available at this time

New BRIUMVI® (ublituximab-xiiy) Data from the ENHANCE Phase 3b Study Show Rapid 30-Minute Infusions are Well Tolerated in Patients with Relapsing Forms of Multiple Sclerosis

healthtechzone.com - 11:15

Sorry! Image not available at this time

These multiple dementia risk factors increase cognitive decline

knowridge.com - 05/Sep 15:25

Cognitive decline and dementia can be caused by illnesses like Alzheimer’s disease and conditions like high blood pressure, which damage blood...

Sorry! Image not available at this time

Boosting brain protein levels may slow Alzheimer’s progression

knowridge.com - 13/Sep 10:32

A new study published in the journal Brain reveals that increasing levels of a key brain protein might help slow cognitive decline in Alzheimer’s...

Sorry! Image not available at this time

Study finds how oral bacteria can aggravate rheumatoid arthritis

times of india - 08/Sep 17:41

Researchers at Tokyo Medical and Dental University have found that the periodontal bacterium Aggregatibacter actinomycetemcomitans exacerbates...

Les derniers communiqués